Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 12 2023
Historique:
received: 27 03 2023
revised: 11 06 2023
accepted: 25 06 2023
medline: 4 12 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: ppublish

Résumé

Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS) is an autosomal recessive neurodegenerative disease, usually caused by biallelic AAGGG repeat expansions in RFC1. In this study, we leveraged whole genome sequencing data from nearly 10 000 individuals recruited within the Genomics England sequencing project to investigate the normal and pathogenic variation of the RFC1 repeat. We identified three novel repeat motifs, AGGGC (n = 6 from five families), AAGGC (n = 2 from one family) and AGAGG (n = 1), associated with CANVAS in the homozygous or compound heterozygous state with the common pathogenic AAGGG expansion. While AAAAG, AAAGGG and AAGAG expansions appear to be benign, we revealed a pathogenic role for large AAAGG repeat configuration expansions (n = 5). Long-read sequencing was used to characterize the entire repeat sequence, and six patients exhibited a pure AGGGC expansion, while the other patients presented complex motifs with AAGGG or AAAGG interruptions. All pathogenic motifs appeared to have arisen from a common haplotype and were predicted to form highly stable G quadruplexes, which have previously been demonstrated to affect gene transcription in other conditions. The assessment of these novel configurations is warranted in CANVAS patients with negative or inconclusive genetic testing. Particular attention should be paid to carriers of compound AAGGG/AAAGG expansions when the AAAGG motif is very large (>500 repeats) or the AAGGG motif is interrupted. Accurate sizing and full sequencing of the satellite repeat with long-read sequencing is recommended in clinically selected cases to enable accurate molecular diagnosis and counsel patients and their families.

Identifiants

pubmed: 37450567
pii: 7224416
doi: 10.1093/brain/awad240
pmc: PMC10689911
doi:

Substances chimiques

RFC1 protein, human 0
CANVAS syndrome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5060-5069

Subventions

Organisme : Medical Research Council
ID : MC_EX_MR/M009203/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009203/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T001712/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_14089
Pays : United Kingdom

Investigateurs

J C Ambrose (JC)
P Arumugam (P)
E L Baple (EL)
M Bleda (M)
F Boardman-Pretty (F)
J M Boissiere (JM)
C R Boustred (CR)
H Brittain (H)
M J Caulfield (MJ)
G C Chan (GC)
C E H Craig (CEH)
L C Daugherty (LC)
A de Burca (A)
A Devereau (A)
G Elgar (G)
R E Foulger (RE)
T Fowler (T)
P Furió-Tarí (P)
E Gustavsson (E)
J M Hackett (JM)
D Halai (D)
A Hamblin (A)
S Henderson (S)
J E Holman (JE)
T J P Hubbard (TJP)
K Ibáñez (K)
R Jackson (R)
L J Jones (LJ)
D Kasperaviciute (D)
M Kayikci (M)
L Lahnstein (L)
K Lawson (K)
S E A Leigh (SEA)
I U S Leong (IUS)
F J Lopez (FJ)
F Maleady-Crowe (F)
J Mason (J)
E M McDonagh (EM)
L Moutsianas (L)
M Mueller (M)
N Murugaesu (N)
A C Need (AC)
C A Odhams (CA)
C Patch (C)
D Perez-Gil (D)
D Polychronopoulos (D)
J Pullinger (J)
T Rahim (T)
A Rendon (A)
P Riesgo-Ferreiro (P)
T Rogers (T)
M Ryten (M)
B Rugginini (B)
K Savage (K)
K Sawant (K)
R H Scott (RH)
A Siddiq (A)
A Sieghart (A)
D Smedley (D)
K R Smith (KR)
A Sosinsky (A)
W Spooner (W)
H E Stevens (HE)
A Stuckey (A)
R Sultana (R)
E R A Thomas (ERA)
S R Thompson (SR)
C Tregidgo (C)
A Tucci (A)
E Walsh (E)
S A Watters (SA)
M J Welland (MJ)
E Williams (E)
K Witkowska (K)
S M Wood (SM)
M Zarowiecki (M)

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

J Neurol. 2021 Sep;268(9):3337-3343
pubmed: 33666721
Brain. 2020 Sep 1;143(9):2673-2680
pubmed: 32851396
Brain. 2020 Feb 1;143(2):480-490
pubmed: 32040566
J Neurol. 2021 Nov;268(11):4280-4290
pubmed: 33884451
Bioinformatics. 2016 Apr 15;32(8):1220-2
pubmed: 26647377
Neurology. 2023 Jan 31;100(5):e543-e554
pubmed: 36289003
Brain. 2021 Jun 22;144(5):1542-1550
pubmed: 33969391
Neurology. 2021 Mar 2;96(9):e1369-e1382
pubmed: 33495376
Int J Biol Macromol. 2022 Apr 15;204:89-102
pubmed: 35124022
Sci Adv. 2022 Mar 4;8(9):eabm5386
pubmed: 35245110
Nucleic Acids Res. 2021 May 21;49(9):4816-4830
pubmed: 33784396
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W676-82
pubmed: 16845096
Brain. 2022 Apr 29;145(3):1139-1150
pubmed: 35355059
N Engl J Med. 2021 Nov 11;385(20):1868-1880
pubmed: 34758253
Brain. 2022 Nov 21;145(11):3770-3775
pubmed: 35883251
Brain. 2022 Jun 30;145(6):2121-2132
pubmed: 34927205
Am J Hum Genet. 2019 Jul 3;105(1):151-165
pubmed: 31230722
Nucleic Acids Res. 2014 Jul;42(13):8379-88
pubmed: 25013182
Brain. 2020 Oct 1;143(10):2904-2910
pubmed: 33103729
Nat Biotechnol. 2021 Apr;39(4):442-450
pubmed: 33257864
Nucleic Acids Res. 2021 Jun 4;49(10):5905-5915
pubmed: 33978746
Nat Biotechnol. 2022 Jul;40(7):1026-1029
pubmed: 34980914
Pract Neurol. 2022 Feb;22(1):14-18
pubmed: 34389644
J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1233-1234
pubmed: 32732387
Nat Genet. 2019 Apr;51(4):649-658
pubmed: 30926972
J Hum Genet. 2020 May;65(5):475-480
pubmed: 32066831
Brain. 2023 May 2;146(5):1831-1843
pubmed: 36227727
Neurology. 2020 Nov 24;95(21):e2912-e2923
pubmed: 32873692
Nat Rev Mol Cell Biol. 2020 Aug;21(8):459-474
pubmed: 32313204
Neurol Genet. 2020 May 20;6(3):e440
pubmed: 32582864
Genetics. 2014 Aug;197(4):1315-27
pubmed: 24879464
Nucleic Acids Res. 2016 Feb 29;44(4):1746-59
pubmed: 26792894
J Neurol. 2022 Nov;269(11):6086-6093
pubmed: 35864213
Eur J Neurol. 2022 Jul;29(7):2156-2161
pubmed: 35253317
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Brain. 2020 Oct 1;143(10):e82
pubmed: 32949124
Nat Commun. 2019 Nov 28;10(1):5436
pubmed: 31780650

Auteurs

Natalia Dominik (N)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.

Stefania Magri (S)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan 20133, Italy.

Riccardo Currò (R)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia 27100, Italy.

Elena Abati (E)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.
Department of Pathophysiology and Transplantation, University of Milan, Milan 20122, Italy.

Stefano Facchini (S)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.
IRCCS Mondino Foundation, Pavia 27100, Italy.

Marinella Corbetta (M)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan 20133, Italy.

Hannah Macpherson (H)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.

Daniela Di Bella (D)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan 20133, Italy.

Elisa Sarto (E)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan 20133, Italy.

Igor Stevanovski (I)

Genomics Pillar, Garvan Institute of Medical Research, Sydney 2010, Australia.
Centre for Population Genomics, Garvan Institute of Medical Research and Murdoch Children's Research Institute, Darlinghurst 2010, Australia.

Sanjog R Chintalaphani (SR)

Centre for Population Genomics, Garvan Institute of Medical Research and Murdoch Children's Research Institute, Darlinghurst 2010, Australia.

Fulya Akcimen (F)

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 2292, USA.

Arianna Manini (A)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.
Department of Pathophysiology and Transplantation, University of Milan, Milan 20122, Italy.
Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan 20145, Italy.

Elisa Vegezzi (E)

IRCCS Mondino Foundation, Pavia 27100, Italy.

Ilaria Quartesan (I)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia 27100, Italy.

Kylie-Ann Montgomery (KA)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.

Valentina Pirota (V)

Department of Chemistry, University of Pavia, Pavia 27100, Italy.
G4-INTERACT, USERN, 27100 Pavia, Italy.

Emmanuele Crespan (E)

Institute of Molecular Genetics IGM-CNR 'Luigi Luca Cavalli-Sforza', Pavia 27100, Italy.

Cecilia Perini (C)

Institute of Molecular Genetics IGM-CNR 'Luigi Luca Cavalli-Sforza', Pavia 27100, Italy.

Glenda Paola Grupelli (GP)

Institute of Molecular Genetics IGM-CNR 'Luigi Luca Cavalli-Sforza', Pavia 27100, Italy.

Pedro J Tomaselli (PJ)

Department of Neurology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto 2650, Brazil.

Wilson Marques (W)

Department of Neurology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto 2650, Brazil.

Joseph Shaw (J)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.

James Polke (J)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.

Ettore Salsano (E)

Clinic of Central and Peripheral Degenerative Neuropathies Unit, IRCCS Foundation, C. Besta Neurological Institute, Milan 20126, Italy.

Silvia Fenu (S)

Clinic of Central and Peripheral Degenerative Neuropathies Unit, IRCCS Foundation, C. Besta Neurological Institute, Milan 20126, Italy.

Davide Pareyson (D)

Clinic of Central and Peripheral Degenerative Neuropathies Unit, IRCCS Foundation, C. Besta Neurological Institute, Milan 20126, Italy.

Chiara Pisciotta (C)

Clinic of Central and Peripheral Degenerative Neuropathies Unit, IRCCS Foundation, C. Besta Neurological Institute, Milan 20126, Italy.

George K Tofaris (GK)

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.

Andrea H Nemeth (AH)

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK.
Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7HE, UK.

John Ealing (J)

Salford Royal NHS Foundation Trust Greater Manchester Neuroscience Centre, Manchester Centre for Clinical Neurosciences Salford, Greater Manchester M6 8HD, UK.

Aleksandar Radunovic (A)

Barts MND Centre, Royal London Hospital, London E1 1BB, UK.

Seamus Kearney (S)

Department of Neurology, Royal Victoria Hospital, Belfast BT12 6BA, UK.

Kishore R Kumar (KR)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
Molecular Medicine Laboratory, Concord Hospital, Concord, NSW 2139, Australia.
Concord Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2139, Australia.

Steve Vucic (S)

Concord Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2139, Australia.
Brain and Nerve Research Centre, Concord Hospital, Sydney, NSW 2139, Australia.

Marina Kennerson (M)

Molecular Medicine Laboratory, Concord Hospital, Concord, NSW 2139, Australia.
Northcott Neuroscience Laboratory, ANZAC Research Institute SLHD, Sydney, NSW 2050, Australia.
School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia.

Mary M Reilly (MM)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.

Henry Houlden (H)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.

Ira Deveson (I)

Genomics Pillar, Garvan Institute of Medical Research, Sydney 2010, Australia.

Arianna Tucci (A)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.

Franco Taroni (F)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan 20133, Italy.

Andrea Cortese (A)

Department of Neuromuscular Diseases, University College London, London WC1N 3BG, UK.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia 27100, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH